Illumina Signs Genotyping Services Agreement With Placer LLC.
Illumina Inc. announced that it has signed a commercial agreement with Placer LLC to provide single nucleotide polymorphism genotyping services on a sample collection provided by Placer. Under the terms of the agreement, Illumina will use its BeadArray technology to genotype specified SNPs in the sample set. Illumina will also design functional assays for the SNP loci, which are believed to be associated with psoriasis and other common skin conditions.
